Back

Sodium-glucose co-transporter-2 inhibitors as oral antidiabetic in patients wit heart failure

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Comorbodities co-morbidities (other) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mr Jose Morgado

University Hospital of Virgen Macarena, Seville (Spain)

29 More presentations in this session

Presentation thumbnail
Chemotherapy-induced cardiotoxicity in a Colombian heart failure program
Doctor C. Saldarriaga (Medellin, CO)
Abstract Slides
Presentation thumbnail
Cardiovascular monitoring and management in cancer patients: a french national survey
Presentation thumbnail
Subgroups analyses of a prospective long-term study in patients with advanced cancer - the prognostic impact of elevated heart rate.
Doctor M. Anker (Berlin, DE)
Abstract
Presentation thumbnail
The cumulative effect of chemoradiotherapy in the risk of developing cardiotoxicity
Doctor A. Gomes (Almada, PT)
Abstract
Presentation thumbnail
Risk factors for heart failure after epirubicin chemotherapy for breast or colorectal cancer
Doctor G. Fogarassy (Balatonfured, HU)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Comorbodities

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources